Drug Profile
MK 0867
Alternative Names: MK-0867Latest Information Update: 30 Jan 2008
Price :
$50
*
At a glance
- Originator Merck & Co
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Endocrine disorders
Most Recent Events
- 01 Aug 2006 Phase-I clinical trials in Endocrine disorders in USA (unspecified route)
- 31 Aug 2005 Phase-I clinical trials in Endocrine disorders in USA (unspecified route)